South and Central America Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)
Market Introduction
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed and used within a single laboratory. These tests can be utilized to estimate or distinguish an extensive assortment of analytes materials such as proteins, chemical compounds like glucose or cholesterol, or DNA, from a specimen received from human anatomy. The expansion of automated in vitro diagnostics (IVD) methods for labs and dispensaries to render precise, and error-free analysis is anticipated to fuel the increment.
Get more information on this report :
Market Overview and Dynamics
The South and Central America laboratory developed test market is expected to reach US$ 1,293.92 million by 2028 from US$ 834.55 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The key factors driving the market's growth are the increasing incidence of cancer and genetic disorders and the growing number of product launches for laboratory developed tests. However, the changing regulatory landscape is hampering the growth of the South and Central America laboratory development test market.
Cancer is one of the leading causes of death worldwide. As per the WHO, cancer was a cause of ~9.6 million deaths in 2018. Clinical diagnostics helps in detecting early signs and risk factors, paving the way for early intervention. The laboratory developed tests (LDTs) have a decisive impact on each step of diagnosis, from screening to the prevention of certain diseases and early diagnosis at the onset of illness. For instance, the Oncotype DX lab test is used to determine if chemotherapy would benefit patients with early-stage breast cancer. It also helps evaluate the likelihood of disease recurrence; the test is performed on a small tissue sample removed during breast cancer surgery. In addition, the increasing incidence of genetic disorders is also driving the demand for LDTs. Many LDTs are available for genetic testing due to a lack of availability of genetic tests in the market. As per the Association for Molecular Pathology 2018 assessment, ~70,000 genetic tests are available in the medical market, and most of these are LDTs. Therefore, the rising incidence of cancer and growing awareness regarding the importance of early diagnostics are boosting the adoption of LDTs. Also, LDTs are developed and used within laboratories and are not distributed or sold to other laboratories or healthcare facilities. Thus, the frequency of development and introduction of new LDTs is high. Additionally, the increasing emergence of SARS-CoV-2 variants has highlighted the need to identify, trace, and track mutations across the complete viral genome. Hence, increasing research on developing LDTs to detect cancer and autoimmune diseases is driving the market growth.
The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. State-run hospitals and clinics are already overstressed by the treatment of vector?borne diseases, community?acquired infections, and high rates of non?communicable diseases (NCDs). As per the Pan American Health Organization (PAHO), the prevention and treatment of NCDs have been critically affected since the onset of the COVID-19 in the region. Moreover, in South and Central America, the gross domestic product (GDP) and central government healthcare expenditure are significantly lower in developed countries. The increasing COVID-19 cases have severely disrupted the care for many chronic diseases, thereby hindering market growth in the region.
Key Market Segments
The South and Central America laboratory developed test market, by type, is segmented into clinical biochemistry, critical care, haematology, microbiology, molecular diagnostics, immunology, and other test types. The haematology segment is sub-segmented into coagulation and hemostasis, hemoglobin testing, blood count testing, and others. The molecular diagnostics segment is expected to hold the largest market share in 2021. However, the haematology segment is anticipated to register the highest CAGR during the forecast period.
The South and Central America laboratory developed test market, by application, is segmented into academic institutes, clinical research organizations, hospitals laboratory, specialty diagnostic centers, and others. The hospitals laboratory segment is expected to hold the largest market share in 2021. However, the specialty diagnostic centers segment is anticipated to register the highest CAGR during the forecast period.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of South and Central America laboratory developed test market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the South and Central America laboratory developed test market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America laboratory developed test market.
SOUTH AND CENTRAL AMERICA LABORATORY DEVELOPED TEST MARKET SEGMENTATION
By Type
- Clinical Biochemistry
- Critical Care
- Haematology
- Coagulation and Hemostasis,
- Hemoglobin Testing
- Blood Count Testing
- Others
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
By Application
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Guardant Health
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Laboratory Developed Test Market – By Type
1.3.2 South and Central America Laboratory Developed Test Market – By Application
1.3.3 South and Central America Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –South and Central America Analysis
6.1 South and Central America Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market –South and Central America Analysis
9.1 South and Central America: Laboratory Developed Test Market
9.1.1 Overview
9.1.2 South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.3 South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 South and Central America: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.4 South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 South and Central America: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.5.1 Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 Brazil Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2.1 Brazil: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.1.3 Brazil Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Argentina Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2.1 Argentina: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.2.3 Argentina Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Rest of South and Central America Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2.1 Rest of South and Central America: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.3.3 Rest of South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on South and Central America Laboratory Developed Test Market
10.1 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Guardant Health
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America Africa Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 14. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 15. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. South and Central America Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. South and Central America Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 8. South and Central America Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 10. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 22. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South and Central America: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. South and Central America Laboratory Developed Test Market Revenue and Forecast to 2028 (USD Million)
Figure 29. South and Central America: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 30. Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in South and Central America Market
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Guardant Health
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.